These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


760 related items for PubMed ID: 8970502

  • 1. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH, McNamara RK, Watterson JM, Watson DG.
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [Abstract] [Full Text] [Related]

  • 2. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG, Watterson JM, Lenox RH.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of the myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP) in the prefrontal cortex and hippocampus of suicide victims.
    McNamara RK, Hyde TM, Kleinman JE, Lenox RH.
    J Clin Psychiatry; 1999 Apr; 60 Suppl 2():21-6; discussion 40-1, 113-6. PubMed ID: 10073384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neurobiology of lithium: an update.
    Lenox RH, McNamara RK, Papke RL, Manji HK.
    J Clin Psychiatry; 1998 Apr; 59 Suppl 6():37-47. PubMed ID: 9674936
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative distribution of myristoylated alanine-rich C kinase substrate (MARCKS) and F1/GAP-43 gene expression in the adult rat brain.
    McNamara RK, Lenox RH.
    J Comp Neurol; 1997 Mar 03; 379(1):48-71. PubMed ID: 9057112
    [Abstract] [Full Text] [Related]

  • 10. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells.
    Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H, Thyagarajan R, Mallon BS, Altar CA.
    J Neurochem; 2004 Oct 03; 91(1):238-51. PubMed ID: 15379904
    [Abstract] [Full Text] [Related]

  • 11. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
    Plant KE, Anderson E, Simecek N, Brown R, Forster S, Spinks J, Toms N, Gibson GG, Lyon J, Plant N.
    Toxicol Appl Pharmacol; 2009 Feb 15; 235(1):124-34. PubMed ID: 19101580
    [Abstract] [Full Text] [Related]

  • 12. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE, McElroy SL.
    J Clin Psychiatry; 2002 Feb 15; 63 Suppl 10():13-7. PubMed ID: 12392348
    [Abstract] [Full Text] [Related]

  • 13. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
    Manji HK, Chen G, Hsiao JK, Risby ED, Masana MI, Potter WZ.
    J Clin Psychiatry; 1996 Feb 15; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells.
    Wang L, Liu X, Lenox RH.
    Biochem Biophys Res Commun; 2002 Apr 12; 292(4):969-79. PubMed ID: 11944910
    [Abstract] [Full Text] [Related]

  • 15. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M, Nishino S, Ohtomo K, Rai M, Shirakawa H, Mashiko H, Niwa S, Nakahata N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):600-4. PubMed ID: 17258372
    [Abstract] [Full Text] [Related]

  • 16. Effect of myristoylated alanine-rich C kinase substrate (MARCKS) overexpression on hippocampus-dependent learning and hippocampal synaptic plasticity in MARCKS transgenic mice.
    McNamara RK, Hussain RJ, Simon EJ, Stumpo DJ, Blackshear PJ, Abel T, Lenox RH.
    Hippocampus; 2005 Apr 13; 15(5):675-83. PubMed ID: 15889447
    [Abstract] [Full Text] [Related]

  • 17. Involvement of the theta-type protein kinase C in translocation of myristoylated alanine-rich C kinase substrate (MARCKS) during myogenesis of chick embryonic myoblasts.
    Kim SS, Kim JH, Kim HS, Park DE, Chung CH.
    Biochem J; 2000 Apr 01; 347 Pt 1(Pt 1):139-46. PubMed ID: 10727412
    [Abstract] [Full Text] [Related]

  • 18. Differential changes in the phosphorylation of the protein kinase C substrates myristoylated alanine-rich C kinase substrate and growth-associated protein-43/B-50 following Schaffer collateral long-term potentiation and long-term depression.
    Ramakers GM, McNamara RK, Lenox RH, De Graan PN.
    J Neurochem; 1999 Nov 01; 73(5):2175-83. PubMed ID: 10537078
    [Abstract] [Full Text] [Related]

  • 19. Expression and phosphorylation of a MARCKS-like protein in gastric chief cells: further evidence for modulation of pepsinogen secretion by interaction of Ca2+/calmodulin with protein kinase C.
    Raufman JP, Malhotra R, Xie Q, Raffaniello RD.
    J Cell Biochem; 1997 Mar 01; 64(3):514-23. PubMed ID: 9057109
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons.
    Li B, Zhang S, Li M, Zhang H, Hertz L, Peng L.
    Neuropharmacology; 2009 Sep 01; 57(4):375-85. PubMed ID: 19596362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.